about
ADC Therapeutics SA is a commercial-stage oncology-focused biotechnology company. It is involved in the development of antibody-drug conjugates for patients suffering from hematological malignancies and solid tumors. The company's FDA-approved and ma...
Read More
4.11
-0.08
(-1.91%)
541.2K
XNYS Volume
XNYS 06 Mar, 2026 4:30 PM (EST)
Board Meeting
The next board meeting for Adc Therapeutics SA is on 10 Mar 2026 for the purpose of ADC Therapeutics SA Fourth Quarter Earnings Conference Call for 2025
See details
Not Eligible
Expensive Valuation
Technically Neutral
Adc Therapeutics SA Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..